Antimicrobial resistance (AMR) is now recognized as a major global public health problem which has been aggravated by the irrational use of antimicrobial agents in human and animal health as well as the presence of these agents in the environment.

Antimicrobial resistance (AMR) – the ability of microbes to resist antimicrobials – remains an alarming global health threat. This is despite the efforts made by OECD and EU/EEA countries to curtail it.

Antimicrobial resistance (AMR) is projected to cause substantial morbidity and mortality in the World Health Organization (WHO) Western Pacific Region over the next decade, at significant economic cost.

Antimicrobial resistance (AMR) is an emerging public health crisis, particularly in low-and middle-income countries, where knowledge gaps are more dominant. The pandemic has further enhanced AMR with long-term repercussions, exacerbating social vulnerabilities.

The Global Action Plan on HIV drug resistance 2017–2021 provided a comprehensive framework for global and country action and outlined a package of interventions and resources to guide the collective response to HIV drug resistance.

This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector.

Up to 10 million people could die annually by 2050 due to anti-microbial resistance (AMR), the UN Environment Programme (UNEP) said in this report, highlighting the need to curtail pollution created by the pharmaceuticals, agricultural and healthcare sectors.

The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR.

Antimicrobial resistance (AMR) occurs when germs, including bacteria, viruses, fungi and parasites change over time and no longer respond to antimicrobials – antibiotics, antivirals, antifungals and antiparasitic agents – making infections harder to treat and increasing the risk of disease spread, severe illness and death.

This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector.